Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

439 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
KRAS mutation in stage III colon cancer and clinical outcome following intergroup trial CALGB 89803.
Ogino S, Meyerhardt JA, Irahara N, Niedzwiecki D, Hollis D, Saltz LB, Mayer RJ, Schaefer P, Whittom R, Hantel A, Benson AB 3rd, Goldberg RM, Bertagnolli MM, Fuchs CS; Cancer and Leukemia Group B; North Central Cancer Treatment Group; Canadian Cancer Society Research Institute; Southwest Oncology Group. Ogino S, et al. Among authors: goldberg rm. Clin Cancer Res. 2009 Dec 1;15(23):7322-9. doi: 10.1158/1078-0432.CCR-09-1570. Epub 2009 Nov 24. Clin Cancer Res. 2009. PMID: 19934290 Free PMC article. Clinical Trial.
Prospectively randomized North Central Cancer Treatment Group trial of intensive-course fluorouracil combined with the l-isomer of intravenous leucovorin, oral leucovorin, or intravenous leucovorin for the treatment of advanced colorectal cancer.
Goldberg RM, Hatfield AK, Kahn M, Sargent DJ, Knost JA, O'Connell MJ, Krook JE, Maillard JA, Wiesenfeld M, Schaefer PL, Tirona MT, Moertel CG. Goldberg RM, et al. J Clin Oncol. 1997 Nov;15(11):3320-9. doi: 10.1200/JCO.1997.15.11.3320. J Clin Oncol. 1997. PMID: 9363861 Clinical Trial.
Phase I dose-finding and pharmacokinetic trial of irinotecan hydrochloride (CPT-11) using a once-every-three-week dosing schedule for patients with advanced solid tumor malignancy.
Pitot HC, Goldberg RM, Reid JM, Sloan JA, Skaff PA, Erlichman C, Rubin J, Burch PA, Adjei AA, Alberts SA, Schaaf LJ, Elfring G, Miller LL. Pitot HC, et al. Among authors: goldberg rm. Clin Cancer Res. 2000 Jun;6(6):2236-44. Clin Cancer Res. 2000. PMID: 10873073 Clinical Trial.
Impact of T and N substage on survival and disease relapse in adjuvant rectal cancer: a pooled analysis.
Gunderson LL, Sargent DJ, Tepper JE, O'Connell MJ, Allmer C, Smalley SR, Martenson JA, Haller DG, Mayer RJ, Rich TA, Ajani JA, Macdonald JS, Goldberg RM. Gunderson LL, et al. Among authors: goldberg rm. Int J Radiat Oncol Biol Phys. 2002 Oct 1;54(2):386-96. doi: 10.1016/s0360-3016(02)02945-0. Int J Radiat Oncol Biol Phys. 2002. PMID: 12243812 Clinical Trial.
Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: a pooled analysis.
Gunderson LL, Sargent DJ, Tepper JE, Wolmark N, O'Connell MJ, Begovic M, Allmer C, Colangelo L, Smalley SR, Haller DG, Martenson JA, Mayer RJ, Rich TA, Ajani JA, MacDonald JS, Willett CG, Goldberg RM. Gunderson LL, et al. Among authors: goldberg rm. J Clin Oncol. 2004 May 15;22(10):1785-96. doi: 10.1200/JCO.2004.08.173. Epub 2004 Apr 5. J Clin Oncol. 2004. PMID: 15067027
Prognostic value of proliferation, apoptosis, defective DNA mismatch repair, and p53 overexpression in patients with resected Dukes' B2 or C colon cancer: a North Central Cancer Treatment Group Study.
Garrity MM, Burgart LJ, Mahoney MR, Windschitl HE, Salim M, Wiesenfeld M, Krook JE, Michalak JC, Goldberg RM, O'Connell MJ, Furth AF, Sargent DJ, Murphy LM, Hill E, Riehle DL, Meyers CH, Witzig TE; North Central Cancer Treatment Group. Garrity MM, et al. Among authors: goldberg rm. J Clin Oncol. 2004 May 1;22(9):1572-82. doi: 10.1200/JCO.2004.10.042. J Clin Oncol. 2004. PMID: 15117979
Phase III study of adjuvant chemotherapy and radiation therapy compared with chemotherapy alone in the surgical adjuvant treatment of colon cancer: results of intergroup protocol 0130.
Martenson JA Jr, Willett CG, Sargent DJ, Mailliard JA, Donohue JH, Gunderson LL, Thomas CR Jr, Fisher B, Benson AB 3rd, Myerson R, Goldberg RM. Martenson JA Jr, et al. Among authors: goldberg rm. J Clin Oncol. 2004 Aug 15;22(16):3277-83. doi: 10.1200/JCO.2004.01.029. Epub 2004 Jul 12. J Clin Oncol. 2004. PMID: 15249584 Clinical Trial.
439 results